Heparin cofactor II activation by dermatan sulfate.
Tollefsen
D M
DM
Department of Medicine, Washington University Medical School, St. Louis, Missouri 63110.
Maimone
M M
MM
McGuire
E A
EA
Peacock
M E
ME
D000818:Animals; D000991:Antithrombins / Q000378:metabolism*; D002807:Chondroitin / Q000031:analogs & derivatives*; D003871:Dermatan Sulfate / Q000494:pharmacology*; D005347:Fibroblasts / Q000378:metabolism; D006023:Glycoproteins / Q000378:metabolism*; D006025:Glycosaminoglycans / Q000494:pharmacology; D006493:Heparin / Q000494:pharmacology; D015844:Heparin Cofactor II; D007700:Kinetics; D009131:Muscle, Smooth, Vascular / Q000378:metabolism; D013917:Thrombin / Q000037:antagonists & inhibitors
D000991:Antithrombins; D006023:Glycoproteins; D006025:Glycosaminoglycans; D003871:Dermatan Sulfate; D015844:Heparin Cofactor II; D006493:Heparin; D002807:Chondroitin; D013917:Thrombin